Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part.
This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.
| Publicado en: | JAMA Oncology Vol. 10; no. 11; pp. 1491 - 1493 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
American Medical Association
Nov2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses. |
|---|